Filing Details
- Accession Number:
- 0001209191-21-001724
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-05 21:03:46
- Reporting Period:
- 2021-01-04
- Accepted Time:
- 2021-01-05 21:03:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1595893 | Turning Point Therapeutics Inc. | TPTX | Pharmaceutical Preparations (2834) | 463826166 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654482 | Mohammad Hirmand | C/O Turning Point Therapeutics, Inc. 10628 Science Center Drive, Ste. 200 San Diego CA 92121 | Evp And Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-04 | 8,747 | $54.73 | 9,331 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-04 | 300 | $122.44 | 9,031 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-04 | 8,747 | $120.42 | 284 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-01-05 | 1,253 | $54.73 | 1,537 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-05 | 1,253 | $120.00 | 284 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-01-04 | 8,747 | $0.00 | 8,747 | $54.73 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-01-05 | 1,253 | $0.00 | 1,253 | $54.73 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 170,445 | 2029-12-01 | No | 4 | M | Direct | |
| 169,192 | 2029-12-01 | No | 4 | M | Direct |
Footnotes
- Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020.
- The Reporting Person acquired 300 shares on June 12, 2020 pursuant to the Issuer's Employee Stock Purchase Plan (the "ESPP") and 284 shares on December 10, 2020 pursuant the ESPP.
- The weighted average sale price for the transaction reported was $120.42, and the range of prices were between $120.00 and $121.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- 25% of the shares vest on December 2, 2020 and 1/48th of the shares vest monthly thereafter over the next three years.
Billionaire Hedge Funds
